company background image
300765 logo

CSPC Innovation Pharmaceutical XSEC:300765 Stock Report

Last Price

CN¥28.62

Market Cap

CN¥39.9b

7D

0.5%

1Y

32.1%

Updated

01 Feb, 2025

Data

Company Financials +

CSPC Innovation Pharmaceutical Co., Ltd.

XSEC:300765 Stock Report

Market Cap: CN¥39.9b

300765 Stock Overview

Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. More details

300765 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Rewards

Trading at 13.5% below our estimate of its fair value

Earnings are forecast to grow 40.47% per year

Analysts in good agreement that stock price will rise by 46.6%

Risk Analysis

High level of non-cash earnings

Dividend of 0.93% is not well covered by free cash flows


My Notes

Capture your thoughts, links and company narrative

CSPC Innovation Pharmaceutical Co., Ltd. Competitors

Dong-E-E-JiaoLtd

SZSE:000423

CN¥39.0b

Humanwell Healthcare (Group)Ltd

SHSE:600079

CN¥35.0b

Changchun High-Tech Industry (Group)

SZSE:000661

CN¥37.7b

Sichuan Kelun Pharmaceutical

SZSE:002422

CN¥44.6b

Price History & Performance

Summary of share price highs, lows and changes for CSPC Innovation Pharmaceutical
Historical stock prices
Current Share PriceCN¥28.62
52 Week HighCN¥37.08
52 Week LowCN¥19.69
Beta-0.18
1 Month Change12.46%
3 Month Change13.98%
1 Year Change32.14%
3 Year Change310.49%
5 Year Change355.02%
Change since IPO394.92%

Recent News & Updates

Recent updates

Shareholder Returns

300765CN PharmaceuticalsCN Market
7D0.5%0.2%-0.9%
1Y32.1%12.8%22.0%

Return vs Industry: 300765 exceeded the CN Pharmaceuticals industry which returned 12.8% over the past year.

Return vs Market: 300765 exceeded the CN Market which returned 22% over the past year.

Price Volatility

Is 300765's price volatile compared to industry and market?
300765 volatility
300765 Average Weekly Movement6.9%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.7%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 300765 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300765's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20061,887Feng Hanwww.xnwpharma.net

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd.

CSPC Innovation Pharmaceutical Co., Ltd. Fundamentals Summary

How do CSPC Innovation Pharmaceutical's earnings and revenue compare to its market cap?
300765 fundamental statistics
Market capCN¥39.86b
Earnings (TTM)CN¥513.13m
Revenue (TTM)CN¥2.04b

77.7x

P/E Ratio

19.5x

P/S Ratio

Is 300765 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300765 income statement (TTM)
RevenueCN¥2.04b
Cost of RevenueCN¥1.20b
Gross ProfitCN¥844.52m
Other ExpensesCN¥331.39m
EarningsCN¥513.13m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 21, 2025

Earnings per share (EPS)0.37
Gross Margin41.33%
Net Profit Margin25.11%
Debt/Equity Ratio0%

How did 300765 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

72%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 04:33
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CSPC Innovation Pharmaceutical Co., Ltd. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shitong HanCitic Securities Co., Ltd.
null nullCLSA
Zhijie ZhaoCLSA